Literature DB >> 9251903

Time course of the changes in central nitric oxide synthase activity following chronic treatment with morphine in the mouse: reversal by naltrexone.

S Kumar1, H N Bhargava.   

Abstract

1. The time course of the effect of chronic administration of morphine on the activity of nitric oxide synthase (NOS) in the brain regions and spinal cord of the mouse was determined. The effect of naltrexone by itself on the NOS activity and that induced by morphine also were determined. 2. Male Swiss Webster mice were implanted subcutaneously with a pellet containing 25 mg of morphine free base for 4 days. Placebo pellet implanted mice served as controls. 3. Twenty-four hours after treatment with morphine, NOS activity decreased in the cerebellum, midbrain, cortex and remainder of the brain as well as in the spinal cord. Forty-eight and 72 hr after the treatment with morphine, NOS activity increased in the cerebellum and cortex, but no change was observed in the other brain regions and spinal cord. Twenty-four hours after morphine pellet removal (withdrawal), NOS activity in all brain regions and the spinal cord has returned to normal. 4. Implantation of a pellet containing 10 mg of naltrexone did not alter NOS activity in any brain region or spinal cord for 24, 48 and 72 hr or 24 hr after removal of the pellet. 5. Implantation of a naltrexone pellet in conjunction with a morphine pellet blocked the changes in NOS activity in the brain region and spinal cord induced by morphine. 6. It is concluded that the initial decrease in NOS activity by morphine may be related to enhanced motor activity, whereas the increase in NOS activity in certain brain regions may be associated with tolerance-physical dependence development. Additionally, the changes in central NOS activity by morphine appear to be mediated by opioid receptors because they were blocked by concurrent treatment with naltrexone.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9251903     DOI: 10.1016/s0306-3623(96)00416-8

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  6 in total

1.  Modulatory role of the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine (ADMA), in morphine tolerance and dependence in mice.

Authors:  Ozgur Gunduz; Cetin Hakan Karadag; Ahmet Ulugol
Journal:  J Neural Transm (Vienna)       Date:  2010-07-27       Impact factor: 3.575

2.  Hyperbaric oxygen treatment suppresses withdrawal signs in morphine-dependent mice.

Authors:  Daniel Nicoara; Yangmiao Zhang; Jordan T Nelson; Abigail L Brewer; Prianka Maharaj; Shea N DeWald; Donald Y Shirachi; Raymond M Quock
Journal:  Brain Res       Date:  2016-08-14       Impact factor: 3.252

3.  Venlafaxine inhibits naloxone-precipitated morphine withdrawal symptoms: Role of inflammatory cytokines and nitric oxide.

Authors:  Mohammad Taghi Mansouri; Bahareh Naghizadeh; Behnam Ghorbanzadeh; Neda Amirgholami; Gholamreza Houshmand; Soheila Alboghobeish
Journal:  Metab Brain Dis       Date:  2019-10-19       Impact factor: 3.584

4.  Changes in anxiety in abstinence correlate with the state of the nigrostriatal system in the rat hippocampus.

Authors:  D I Peregud; O N Vorontsova; A A Yakovlev; L F Panchenko; N V Gulyaeva
Journal:  Neurosci Behav Physiol       Date:  2008-07-08

5.  Nitroxidergic modulation of behavioural, cardiovascular and immune responses, and brain NADPH diaphorase activity upon morphine tolerance/dependence in rats.

Authors:  Ana Tsakova; Slavina Surcheva; Katerina Simeonova; Iskra Altankova; Tsvetanka Marinova; Kamen Usunoff; Mila Vlaskovska
Journal:  Biotechnol Biotechnol Equip       Date:  2014-12-13       Impact factor: 1.632

6.  How Nitric Oxide Increases in Diabetic Morphine Tolerated Male Rats.

Authors:  Yassar Mortada; Khojasteh Khojasteh; Malek Zarei; Ardalan Mansouri; Masoumeh Jorjani
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.